Invesaro

Stocks Comparison

Medpace vs Nrc Health: revenue, profit, margins and growth compared

Medpace brought in $2.5B of revenue in fiscal 2025, Nrc Health $137.4M in fiscal 2025. Revenue changed by +20.0% at Medpace and -4.0% at Nrc Health on the year before, so Medpace grew faster. Medpace kept 17.8% of its revenue as net profit, Nrc Health 8.2%. Free cash flow was $681.9M at Medpace and $15.7M at Nrc Health.

Side by side, latest fiscal year

MEDPNRC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.5B$137.4M
Revenue growth+20.0%-4.0%
Net income$451.1M$11.3M
Net margin17.8%8.2%
Free cash flow$681.9M$15.7M
Free cash flow margin26.9%11.5%
Earnings per share (diluted)$15.28$50.00
Cash$497M$4.1M
Debtn/a$79M
Price to earnings40.50.4
Market value$17.3B$432.9M
Dividend yieldn/a2.66%
Rank by revenue in sector#94 of 523 · Health care#278 of 523 · Health care

Over the years

Revenue
MEDP FY2018: $704.6MMEDP FY2019: $861MMEDP FY2020: $925.9MMEDP FY2021: $1.1BMEDP FY2022: $1.5BMEDP FY2023: $1.9BMEDP FY2024: $2.1BMEDP FY2025: $2.5BNRC FY2018: $119.7MNRC FY2019: $128MNRC FY2020: $133.3MNRC FY2021: $148MNRC FY2022: $151.6MNRC FY2023: $148.6MNRC FY2024: $143.1MNRC FY2025: $137.4MFY18FY19FY20FY21FY22FY23FY24FY25
MEDP $2.5BNRC $137.4M
Net income
MEDP FY2018: $73.2MMEDP FY2019: $100.4MMEDP FY2020: $145.4MMEDP FY2021: $181.8MMEDP FY2022: $245.4MMEDP FY2023: $282.8MMEDP FY2024: $404.4MMEDP FY2025: $451.1MNRC FY2018: $30MNRC FY2019: $32.4MNRC FY2020: $37.2MNRC FY2021: $37.4MNRC FY2022: $31.8MNRC FY2023: $31MNRC FY2024: $24.8MNRC FY2025: $11.3MFY18FY19FY20FY21FY22FY23FY24FY25
MEDP $451.1MNRC $11.3M
Net margin
MEDP FY2018: 10.4%MEDP FY2019: 11.7%MEDP FY2020: 15.7%MEDP FY2021: 15.9%MEDP FY2022: 16.8%MEDP FY2023: 15.0%MEDP FY2024: 19.2%MEDP FY2025: 17.8%NRC FY2018: 25.1%NRC FY2019: 25.3%NRC FY2020: 27.9%NRC FY2021: 25.3%NRC FY2022: 21.0%NRC FY2023: 20.8%NRC FY2024: 17.3%NRC FY2025: 8.2%FY18FY19FY20FY21FY22FY23FY24FY25
MEDP 17.8%NRC 8.2%
Revenue growth
MEDP FY2019: +22.2%MEDP FY2020: +7.5%MEDP FY2021: +23.4%MEDP FY2022: +27.8%MEDP FY2023: +29.2%MEDP FY2024: +11.8%MEDP FY2025: +20.0%NRC FY2019: +6.9%NRC FY2020: +4.1%NRC FY2021: +11.0%NRC FY2022: +2.4%NRC FY2023: -2.0%NRC FY2024: -3.7%NRC FY2025: -4.0%FY19FY20FY21FY22FY23FY24FY25
MEDP +20.0%NRC -4.0%
Free cash flow
MEDP FY2018: $140.6MMEDP FY2019: $184MMEDP FY2020: $227.3MMEDP FY2021: $235.1MMEDP FY2022: $351.2MMEDP FY2023: $396.7MMEDP FY2024: $572.3MMEDP FY2025: $681.9MNRC FY2018: $33.9MNRC FY2019: $36.3MNRC FY2020: $36.7MNRC FY2021: $40.8MNRC FY2022: $26.4MNRC FY2023: $22.3MNRC FY2024: $19.2MNRC FY2025: $15.7MFY18FY19FY20FY21FY22FY23FY24FY25
MEDP $681.9MNRC $15.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about Medpace and Nrc Health

Which is bigger by revenue, Medpace or Nrc Health?

Medpace is bigger by revenue: $2.5B in fiscal 2025, against $137.4M for Nrc Health in fiscal 2025.

Which keeps more of its revenue as profit, Medpace or Nrc Health?

Medpace had a net margin of 17.8% in fiscal 2025; Nrc Health had 8.2% in fiscal 2025.

Which grew revenue faster, Medpace or Nrc Health?

In their latest fiscal years revenue changed by +20.0% at Medpace and -4.0% at Nrc Health.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies